Korean Drug고려제약
014570 · KOSDAQ · ₩014570 · 고려제약
₩2,810▼ ₩30 (1.06%)End-of-day · Oct 30, 2026 · End-of-day prices.
Filings
- Change of CEO대표이사변경Oct 1, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Imposition of Fines벌금등의부과Jul 10, 2026Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서May 19, 2026Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)May 18, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Change of Department Affiliation소속부변경Apr 30, 2026Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Apr 7, 2026Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Mar 31, 2026Open on DART
- Corporate value-up plan기업가치제고계획(자율공시)Mar 20, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 20, 2026Open on DART
- Audit report submitted감사보고서제출Mar 12, 2026Open on DART
- Added attachment: Annual report (Dec 2025)[첨부추가]사업보고서 (2025.12)Mar 12, 2026Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Mar 5, 2026Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Mar 3, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Feb 25, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Feb 25, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Feb 24, 2026Open on DART
- Cash dividend decision현금ㆍ현물배당결정Feb 24, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 24, 2026Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Jan 7, 2026Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Jan 5, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 15, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Aug 13, 2025Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Aug 11, 2025Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Jul 2, 2025Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Jun 30, 2025Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Jun 5, 2025Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Jun 2, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 21, 2025Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 21, 2025Open on DART
- Audit report submitted감사보고서제출Mar 13, 2025Open on DART
- Annual report (Dec 2024)사업보고서 (2024.12)Mar 13, 2025Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Mar 6, 2025Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Mar 4, 2025Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Feb 26, 2025Open on DART
- Notice of shareholders' meeting주주총회소집공고Feb 26, 2025Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Feb 25, 2025Open on DART
- Shareholders' meeting called주주총회소집결의Feb 25, 2025Open on DART
- Cash dividend decision현금ㆍ현물배당결정Feb 25, 2025Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 25, 2025Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Jan 2, 2025Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Dec 30, 2024Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Dec 18, 2024Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2024Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Dec 16, 2024Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Dec 11, 2024Open on DART
Titles in Korean until English translations are added.
Also known as: Korean Drug / 고려제약 / 014570 / KRX:014570
Source: KRX statistical information